WuXi AppTec logo

WuXi AppTec(OTC) WUXAY

Market Cap$13.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)+57%
5 Year+50%
1 Year+79%
1 Month+10%
$27.67
+1.84%
+0.50Today
WuXi AppTec last closing stock price
MetricPriceDate
Last closeUSD 27.172026-10-05
WuXi AppTec stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.15%USD 26.342026-09-28
1 month+9.9%USD 24.722026-09-04
3 month+38.22%USD 19.662026-07-07
Year to date+118.86%USD 12.412025-12-31
1 year+78.63%USD 15.212025-10-03
3 year+134.73%USD 11.572023-10-06
5 year+49.82%USD 18.132021-09-08
Since inception+57.41%USD 17.262021-02-24

WuXi AppTec Financials at a Glance

Market Cap

$13.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

CN¥53.48B

Net Income (TTM)

CN¥21.65B

EPS (TTM)

$1.06

P/E Ratio

25.15

Dividend

$0.23

Beta (Volatility)

0.58 (Low)

Price

$27.67

Volume

384

Open

$27.62

Previous Close

$27.67

Daily Range

$27.62 - $27.67

52-Week Range

$12.45 - $27.80

Estimated Earnings Date

Oct 27, 2026

WUXAY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About WuXi AppTec

WuXi AppTec Co., Ltd. is a leading global provider of research, development, and manufacturing services for the pharmaceutical and biotechnology industries. The company operates across multiple regions, including China, the United States, and Europe, facilitating the advancement of small molecule pharmaceuticals and cell and gene therapies.

Products and Services
  • Comprehensive contract research and development services
  • Manufacturing capabilities for small molecules and biologics
  • Integrated testing solutions for drugs and medical devices
Growth Outlook
  • Revenue growth of 32% year-over-year in Q2 2026
  • Strong demand for cell and gene therapy services driving expansion
  • Investment in R&D expected to enhance service offerings
Financial Highlights
  • Net income of CNY 6.43 billion in Q2 2026
  • Operating income margin of 48% for the latest quarter
  • TTM return on equity of 27.24% indicates strong profitability
WuXi AppTec Co., Ltd. has established itself as a vital player in the healthcare sector, particularly in the fields of drug development and manufacturing. The company's diverse service offerings cater to a wide range of client needs, from initial discovery to commercial launch. Recent financial performance highlights a robust growth trajectory, with significant revenue increases and strong profit margins. The ongoing investment in research and development positions WuXi AppTec to capitalize on emerging trends in the pharmaceutical industry, particularly in the rapidly evolving area of cell and gene therapies. With a solid foundation and a commitment to innovation, WuXi AppTec presents a compelling opportunity for potential investors interested in the healthcare sector.
AI Generated • Sep 24, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

35,584

CEO

Min Zhang Chen, PhD; Ge Li, PhD; Qing Yang

Website

www.wuxiapptec.com.cn

Headquarters

Shanghai, SH 200131, CN

WUXAY Financials

Key Financial Metrics (TTM)

Gross Margin

51.96%

Operating Margin

42.43%

Net Income Margin

40.47%

Return on Equity

27.24%

Return on Capital

19.33%

Return on Assets

18.58%

Earnings Yield

3.98%

Dividend Yield

0.85%

Payout Ratio

31.55%

Stock Overview

Market Cap

$13.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

514.66M

Volume

384

Avg. Volume

1.78K

Financials (TTM)

Gross Profit

CN¥27.91B

Operating Income

CN¥23.11B

EBITDA

CN¥28.38B

Operating Cash Flow

CN¥26.82B

Capital Expenditure

-CN¥6.38B

Free Cash Flow

CN¥20.44B

Cash & ST Invst.

CN¥46.66B

Total Debt

CN¥15.11B

WuXi AppTec Performance Analysis

WuXi AppTec annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31CNY 5,844,425,23464.6%
20232023-12-31CNY 5,459,126,439-6.6%
20242024-12-31CNY 4,969,799,070-9.0%
20252025-12-31CNY 6,040,359,96221.5%
WuXi AppTec sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-307.5%
Q42025-12-315.2%
Q12026-03-31-1.3%
Q22026-06-3032.4%
WuXi AppTec annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31CNY 0.4255.7%
20232023-12-31CNY 0.5122.2%
20242024-12-31CNY 0.45-12.4%
20252025-12-31CNY 0.92104.7%
WuXi AppTec sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30-28.8%
Q42025-12-31104.1%
Q12026-03-31-36.0%
Q22026-06-3037.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

CN¥16.46B

+47.7%

Gross Profit

CN¥9.35B

+80.9%

Gross Margin

56.77%

N/A

Market Cap

$13.98BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$413.29K

N/A

Employees

33,834

N/A

Net Income

CN¥6.43B

+31.5%

EBITDA

CN¥8.80B

+54.2%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

CN¥46.66B

+91.0%

Total Debt

CN¥15.11B

+107.2%

Accounts Receivable

CN¥13.00B

+55.4%

Inventory

CN¥11.13B

+55.6%

Long Term Debt

CN¥2.19B

+46.3%

Short Term Debt

CN¥12.92B

+122.9%

Return on Assets

18.58%

N/A

Return on Invested Capital

25.86%

N/A

Free Cash Flow

CN¥4.34B

+51.2%

Operating Cash Flow

CN¥6.10B

+44.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRLCharles River Laboratories International, Inc.
$304.96-1.87%
MEDPMedpace Holdings, Inc.
$602.90-2.84%
WXXWYWuXi Biologics (Cayman) Inc.
$14.79+3.43%
IQVIQVIA Holdings Inc.
$260.16-2.23%

Trending Stocks

Symbol / CompanyPricePrice Chg
SPCXSpace Exploration Technologies
$171.92+0.48%
INTCIntel
$112.50-3.18%
NVDANvidia
$239.24+0.14%
NUNu Holdings
$15.66+3.16%

Questions About WUXAY

What is the current price of WuXi AppTec?

WuXi AppTec is trading at $27.67 per share.

What is the 52-week range for WuXi AppTec?

Over the past 52 weeks, WuXi AppTec has traded between $12.45 and $27.80.

How much debt does WuXi AppTec have?

As of the most recent reporting period, WuXi AppTec reported total debt of CN¥2.23B.

How much cash does WuXi AppTec have on hand?

WuXi AppTec reported CN¥3.98B in cash and cash equivalents in its most recent financial results.

What is WuXi AppTec’s dividend yield?

WuXi AppTec currently has a dividend yield of 0.85%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services